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ABSTRACT The PHR (Pam/Highwire/RPM-1) proteins are evolutionarily conserved ubiquitin ligases that regulate axon guidance and
synapse formation in Caenorhabditis elegans, Drosophila, zebraﬁsh, and mice. In C. elegans, RPM-1 (Regulator of Presynaptic
Morphology-1) functions in synapse formation, axon guidance, axon termination, and postsynaptic GLR-1 trafﬁcking. Acting as an
E3 ubiquitin ligase, RPM-1 negatively regulates a MAP kinase pathway that includes: dlk-1, mkk-4, and the p38 MAPK, pmk-3. Here
we provide evidence that ppm-1, a serine/threonine phosphatase homologous to human PP2Ca(PPM1A) and PP2Cb(PPM1B) acts as
a second negative regulatory mechanism to control the dlk-1 pathway. We show that ppm-1 functions through its phosphatase activity
in a parallel genetic pathway with glo-4 and fsn-1 to regulate both synapse formation in the GABAergic motorneurons and axon
termination in the mechanosensory neurons. Our transgenic analysis shows that ppm-1 acts downstream of rpm-1 to negatively
regulate the DLK-1 pathway, with PPM-1 most likely acting at the level of pmk-3. Our study provides insight into the negative
regulatory mechanisms that control the dlk-1 pathway in neurons and demonstrates a new role for the PP2C/PPM phosphatases as
regulators of neuronal development.
T
HE Pam/Highwire/RPM-1 (PHR) proteins are key regu-
lators of neuronal development that function in synapse
formation, axon termination and guidance, axon regen-
eration, and glutamate receptor trafﬁcking (Schaefer et al.
2000; Wan et al. 2000; Zhen et al. 2000; Burgess et al. 2004;
D’Souza et al. 2005; Lewcock et al. 2007; Li et al. 2008;
Hammarlund et al. 2009; Park et al. 2009; Po et al. 2010).
The PHR protein family includes: human Pam, mouse Phr1,
zebraﬁsh esrom/Phr1, Drosophila Highwire and Caenorhab-
ditis elegans Regulator of Presynaptic Morphology (RPM)-1.
PHR proteins function through multiple downstream
signaling pathways. In C. elegans, RPM-1 f u n c t i o n sa sp a r t
of an ubiquitin ligase complex that includes the F-box pro-
tein, F-box Synaptic Protein (FSN)-1 (Liao et al. 2004).
This complex negatively regulates a MAP kinase cascade
that includes dual leucine zipper-bearing kinase (dlk-1),
map kinase kinase (mkk)-4, p38 map kinase (pmk)-3,
map kinase activated protein kinase (mak)-2, and the tran-
scription factor cebp-1 (Nakata et al. 2005; Yan et al. 2009).
Drosophila Highwire and mouse Phr1 negatively regulate
the ortholog of DLK-1 through a similar mechanism
(Collins et al. 2006; Lewcock et al. 2007; Wu et al. 2007;
Saiga et al. 2009; Tada et al. 2009). Phr1 also ubiquitinates
and negatively regulates the tuberin sclerosis complex
(Murthy et al. 2004; D’Souza et al. 2005; Han et al.
2008). RPM-1 positively regulates signaling through
a Rab GTPase pathway by binding to Gut Granule Loss
(GLO)-4 (Grill et al. 2007).
While RPM-1 negatively regulates the DLK-1 pathway,
there are a number of reasons to suspect that the DLK-1
pathway may also be controlled by other negative regula-
tory mechanisms. First, overexpression of dlk-1 causes more
dramatic phenotypes than rpm-1 loss of function (lf), in-
cluding uncoordinated movement and small body size
(Nakata et al. 2005; Abrams et al. 2008). Second, the
dlk-1 pathway consists of ﬁve signaling molecules providing
numerous points where regulation might occur. Third,
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Genetics, Vol. 189, 1297–1307 December 2011 1297ubiquitination is a relatively slow-acting mechanism to re-
strict DLK-1 signaling. The observation that UEV-3 is a pos-
sible positive regulator of PMK-3 (Trujillo et al. 2010)
further supports the idea that multiple mechanisms may
control the DLK-1 pathway.
There is a large body of evidence that MAP kinases are
negatively regulated by phosphatases including MAP kinase-
speciﬁc phosphatases, and broad-acting PP2C/PPM family
phosphatases (Lu and Wang 2008; Shi 2009; Bermudez
et al. 2010). While MAP kinases are known to function in
neurons (Ji et al. 2009; Samuels et al. 2009), the negative
regulatory phosphatases that control MAP kinase signaling
in neurons remain relatively poorly understood.
Here we provide evidence that neuronal development is
regulated by a PP2C/PPM family phosphatase from C. ele-
gans that we call protein phosphatase mg2+/mn2+ depen-
dent (ppm)-1.W eh a v ef o u n dt h a tppm-1 acts through its
phosphatase activity to regulate axon termination and syn-
apse formation by acting in a parallel genetic pathway to
fsn-1 and glo-4.L o s so ff u n c t i o ni nppm-1 is suppressed by
loss of function in pmk-3 (p38 MAPK), suggesting that
ppm-1 negatively regulates pmk-3 activity. This ﬁnding is
consistent with our observation that ppm-1 functions
downstream of rpm-1. Overall, our observations demon-
strate that the DLK-1 pathway is negatively regulated
by at least two mechanisms in neurons: the action of
a Skp, Cullin, F-box (SCF) complex that includes RPM-1
and FSN-1 and the activity of a serine/threonine phospha-
tase, PPM-1.
Materials and Methods
Genetics
C. elegans strains were maintained as described (Brenner
1974). Alleles used in this study include: rpm-1(ju44),
glo-1(zu391), fsn-1(hp1), ppm-1/tag-93(ok578), ppm-1/
tag-93(tm653), dlk-1(ju476), mkk-4(ju91), and pmk-3
(ok169). All double mutants were constructed following
standard procedures, and were conﬁrmed by the associ-
ated phenotypes or by PCR genotyping. glo-4, ppm-1 dou-
ble mutants were constructed by recombination without
using visible markers. Primers and PCR conditions are
available upon request. fsn-1; ok578/tm653 animals were
constructed using dpy-11 linked to ok578,a n dunc-42
linked to tm653. Non-dpy, non-unc animals with the ge-
notype fsn-1; ok578, dpy-11/unc-42, tm653 were scored
for trans-heterozygous analysis. The transgenic strains
used in this study are: muIs32[Pmec-7GFP] (Ch’ng et al.
2003), juIs1[Punc-25SNB-1::GFP] (Hallam and Jin 1998),
bggEx35 [wrm613bH10], bggEx33 [Prgef-1::ppm-1 (cDNA
F25D1.1c)], bggEx34, 40,a n d41 [Pmec-7::ppm-1 (cDNA
F25D1.1c)], bggEX58, 59, 60, 61,a n d62 [Pmec-7::ppm-1
(D246N) (cDNA F25D1.1c)], and bggEx55, 56 and 57
[Pppm-1::GFP].
Transgene constructs
To construct cell-speciﬁc expression vectors of ppm-1,
a ppm-1 cDNA (corresponding to the coding sequence of
F25D1.1c.1) was ampliﬁed by RT–PCR from C. elegans
RNA and cloned into the pCR8-Topo gateway entry vector
(Invitrogen) to create pBG-GY146. pBG-GY146 was recom-
bined into destination vectors containing the rgef-1 promoter,
the mec-7 promoter, or the myo-3 promoter to generate pBG-
GY153 (Prgef-1ppm-1), pBG-GY163 (Pmec-7ppm-1), and pBG-
GY116 (Pmyo-3ppm-1). The D246N point mutant of PPM-1
was generated by site-directed mutagenesis to create pBG-
GY200 (pCR8 TopoGY ppm-1 (D246A). pBG-GY200 was
recombined into destination vectors containing the mec-7 pro-
moter to generate pBG-GY202 (Pmec-7ppm-1 (D246N)). The
fosmid wrm613bH10 and pBA183 (Pmyo-2mCherry) were gifts
from David Greenstein (University of Minnesota) and Brian
Ackley (University of Kansas), respectively.
Transgenic animals were generated as described pre-
viously (Mello et al. 1991). Plasmid DNA of interest was
injected at 1–25 ng/mla l o n gw i t hP ttx-3RFP (50 ng/ml) or
(Pmyo-2mCherry 1.5–2.5 ng/ml) and pBluescript (50
ng/ml). Initially all transgenic animals were generated
on ppm-12/2 backgrounds. To create transgenic animals
that were fsn-1; ppm-1 double mutants, fsn-1; ppm-1
mutants were heat shocked and males were mated to array
positive ppm-1 mutants. For DLK-1 overexpression experi-
ments, Prgef-1::dlk-1 was ampliﬁed by long PCR using
pBG-57 as a template and injected at 5–10 ng/ml. For
rescue experiments with PPM-1, pBG-GY163 (Pmec-7::
ppm-1)o rp B G - G Y 2 0 2( P mec-7::ppm-1 (D246N) were
coinjected at 2 ng/mlw i t hP rgef-1::dlk-1. For analysis of
PPM-1 subcellular distribution, pBG-GY208 (Punc-25::
mCherry-PPM-1) was injected at 5 ng/mli n t oppm-1
(tm653); juIs1 animals.
Axon termination and synapse formation analysis
Analysis was carried out using a Nikon epiﬂuorescent
microscope and a Q-imaging camera at ·40 magniﬁcation.
Live animals were anesthetized using 1% (v/v) 1-phenoxy-
2-propanol in M9 buffer. Axon termination defects were
quantiﬁed by scoring 1–3 pools of worms consisting of 7–
20 animals from three or more independent experiments for
each genotype. The mean for a given phenotype was calcu-
lated and is shown in all histograms. All error bars represent
the standard error of the mean. Statistical signiﬁcance was
calculated using an unpaired t-test. For synapse formation
defects, data were averaged from 20–30 animals from
a minimum of three independent experiments. The error
bars represent the standard error of the mean, and statistical
signiﬁcance was determined using an unpaired t-test.
Results were considered signiﬁcant for axon termination
defects or synapse formation defects if a P value of ,0.05
was obtained. All analysis was done without blinding for
genotypes.
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A PP2Ca/b phosphatase, PPM-1, regulates axon
termination in the mechanosensory neurons of
C. elegans
While the DLK-1 pathway is negatively regulated by RPM-1,
several observations suggest that phosphatases of the PP2C/
PPM family may also inhibit the DLK-1 pathway. Biochemi-
cal experiments in vitro and in mammalian cell culture have
shown that PP2Ca and -b (also called PPM1A and -B) can
dephosphorylate and negatively regulate MKKKs, MKKs, and
MAPKs (Takekawa et al. 1998; Hanada et al. 2001). In yeast,
the homologs of PP2Ca negatively regulate the activity of
High-osmolarity glycerol (Hog)1, the homolog of p38 MAPK
(Maeda et al. 1994; Jacoby et al. 1997; Nguyen and Shiozaki
1999; Saito and Tatebayashi 2004). Further, PP2Ca func-
tions in mammalian neurons to control calcium ﬂux (Li
et al. 2005), suggesting that PP2C phosphatases may have
undiscovered roles in neuronal development.
The C. elegans genome contains a single gene, temporar-
ily assigned gene name (tag)-93 (F25D1.1), whose protein
product is conserved with two PP2C phosphatases in
humans, PP2Ca/PPM1A and PP2Cb/PPM1B (49% identity
Figure 1 ppm-1 regulates axon termination in the ALM neurons. (A) Schematic of the exons (hatched boxes) and introns of three open reading frames
predicted for ppm-1 by WormBase. The deletions caused by ok578 and tm653 are shown below. (B) Schematic of the human PP2Ca protein, and
predicted PPM-1 proteins with the catalytic phosphatase domain (gray), and the regulatory domain (hatched design) highlighted. Shown below
are segments of PPM-1 deleted by ok578 and tm653. Mutagenesis studies on human PP2Ca showed that mutation of residue D60 and D239 led
to 900- and 4000-fold decreases in phosphatase activity, respectively (Jackson et al. 2003). The corresponding conserved residues in PPM-1, D62, and
D246 (F25D1.1c), are shown. (C) Axon termination defects in the ALM mechanosensory neuron were visualized using muIs32[Pmec7GFP] for wild type or
the indicated mutant genotypes. Images correspond to the boxed region of the diagram. (D) Quantitation of the total axon termination defects in
ALM neurons. (E) Quantitation of speciﬁc, short hook (white) or big hook (gray), axon termination defects in the ALM neurons of the indicated
genotypes. Note that the percentage of ALM axons that are normal/wild type for each genotype is not shown. Analysis was performed on
young adults grown at 23 , unless otherwise speciﬁed. Bar, 10 mm. Error bars represent the standard error of the mean. Signiﬁcance was determined
using an unpaired t-test, where n represents the number of independent counts of 10–30 worms for a given genotype. *P , 0.05, **P , 0.01.
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conservation with PPM1B) (Stern et al. 2007) (Figure 1, A
and B). PP2C/PPM phosphatases are single subunit enzymes
that require magnesium/manganese for activity, and consist
of a catalytic domain and a regulatory domain (Lu and
Wang 2008; Shi 2009) (Figure 1B). On the basis of this
homology, we have renamed tag-93 as protein phosphatase
magnesium2+/manganese2+ dependent (ppm)-1.
There are three open reading frames of ppm-1 that are
predicted in the C. elegans genome (F25D1.1a, F25D1.1b,
and F25D1.1c)( www.wormbase.org). One of these open
reading frames, F25D1.1c, encodes a 385-amino-acid pro-
tein that has a conserved start site with mammalian
PP2Ca/PPM1A (data not shown and Figure 1, A and B).
Using RT–PCR, we conﬁrmed the coding sequence of
F25D1.1c, and we used this transcript as our frame of refer-
ence for analysis of two alleles of ppm-1: ok578 and tm653.
We sequenced the lesion in ok578 and found that it deletes
984 bp and inserts two thymidine bases, which causes
a frameshift and leads to loss of wild-type sequence after
amino acid 69. Importantly, ok578 deletes a residue (D246)
that when mutated in mammalian PP2Ca/PPM1A results in
a 4000-fold drop in phosphatase activity (Jackson et al.
2003) (Figure 1B). Sequencing of tm653 conﬁrmed it has
a 1089-bp deletion in the ppm-1 gene that deletes a portion
of the promoter, the start codon, and the ﬁrst 156 amino
acids of PPM-1 including a key catalytic residue (Figure 1B).
These observations show that ok578 and tm653 are molec-
ular null alleles.
Defects in rpm-1(lf) mutants are due, in part, to excess
signaling through the dlk-1 pathway (Nakata et al. 2005;
Grill et al. 2007). We hypothesized that ppm-1(lf) might also
Figure 2 ppm-1 regulates axon termination in the PLM neurons. (A) Axon termination defects in the PLM neurons were visualized using muIs32
[Pmec7GFP] for wild type or the indicated mutant genotypes. Images correspond to the boxed region of the diagram. Arrows mark overextension of the
PLM axon beyond the ALM cell body, and arrowheads mark the more severe phenotype of overextension and hooking of the PLM axon. (B) Quantitation
of the percentage of PLM neurons that only overextend (white) or overextend and hook (gray) for the indicated genotypes. Note that the percentage of
PLM axons that are wild type for each genotype is not shown. Analysis was performed on young adults grown at 23 , unless otherwise speciﬁed. Bar,
10 mm. Error bars represent the standard error of the mean. Signiﬁcance was determined using an unpaired t-test, where n represents the number of
independent counts of 10–30 worms for a given genotype. ***P , 0.001; ns ¼ not signiﬁcant.
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phenotypes that are similar to rpm-1(lf) mutants. To test this
hypothesis, we ﬁrst analyzed the mechanosensory neurons
of ppm-1(lf) mutants.
In wild-type animals, the two anterior lateral microtubule
(ALM) mechanosensory neurons each have a single axon that
terminates at a precise location (Figure 1C). In contrast, axon
termination is defective in the ALM neurons of rpm-1(lf)
mutants (Figure 1, C and D). rpm-1(lf) mutants display two
types of ALM axon termination defects: less severe short
hooks and more severe big hooks where the axon overex-
tends and hooks toward the posterior of the animal (Figure
1, C and E). In rpm-1(lf) mutants, big hooks in the ALM are
the predominant phenotype, and this phenotype is tempera-
ture sensitive for the ju44 allele of rpm-1 (Figure 1E). In
ppm-1(ok578) and ppm-1(tm653) mutants, we observed
small hook defects in the ALM neurons that occurred with
low penetrance (Figure 1, C–E).
Previous studies showed that rpm-1(lf) mutants also have
defects in the posterior lateral microtubule (PLM) neurons,
which fall into two main phenotypic categories: (1) axon
termination defects (Figure 2A) and (2) synaptic branch
extension/stabilization defects (Figure 3A) (Schaefer et al.
2000; Grill et al. 2007). A given PLM neuron can display one
or both of these phenotypes. In rpm-1(lf) mutants, a small
percentage of PLM axons (8%) display a milder axon termi-
nation phenotype in which the PLM axon only overextends
beyond the ALM cell body (Figure 2A, overextension). The
majority of PLM neurons in rpm-1(lf) mutants (90%) display
a more severe phenotype in which the PLM axon overex-
tends beyond the ALM cell body and also hooks ventrally,
which we will refer to as hooking for ease of discussion
(Figure 2A, hook). Both the hooking and synaptic branch
defects in rpm-1(lf) mutants are highly penetrant (Figures
2B and 3B). In ppm-1(ok578) mutants, we observed both
axon termination phenotypes with a larger percentage of
neurons showing the milder overextension phenotype and
a small percentage of neurons showing the more severe
hooking phenotype (Figure 2, A and B). Similar results were
obtained for ppm-1(tm653) (Figure 2B). With regard to syn-
aptic branch extension, ppm-1(lf) animals had defects in
synaptic branch extension that were very low penetrance
(Figure 3, A and B). These results show that ppm-1 regulates
axon termination in the mechanosensory neurons.
ppm-1 functions in parallel to fsn-1 and glo-4 to
regulate axon termination
rpm-1 has two major downstream signaling activities that
are known. rpm-1 functions with fsn-1 to negatively regulate
the dlk-1 pathway (Liao et al. 2004; Nakata et al. 2005) and
binds to GLO-4 to positively regulate the glo pathway, which
includes: glo-4, glo-1 (a Rab GTPase), and apm-3 (Grill et al.
2007). To determine whether ppm-1 functions in either of
these pathways or as part of an independent pathway, we
constructed double mutants between ppm-1 and fsn-1, glo-4,
and glo-1. When total mutant neurons were analyzed, fsn-1;
ppm-1 double mutants had an additive phenotype in the
ALM neurons (Figure 1B). However, an enhanced pene-
trance of big hooks was observed in fsn-1; ppm-1 double
mutants compared to single mutants (Figure 1E). Both
ppm-1(ok578) and ppm-1(tm653) had similar enhancer
effects with fsn-1(lf) (Figure 1E). While the level of big
hooks was mildly increased in both glo-4, ppm-1 and glo-1;
ppm-1 double mutants, these differences were not statisti-
cally signiﬁcant, demonstrating that ppm-1 does not en-
hance the glo pathway in the ALM neurons (Figure 1E).
With regard to the PLM neurons, fsn-1; ppm-1 double
mutants had an enhanced percentage of neurons that show
the hooking phenotype (Figure 2). The penetrance of syn-
aptic branch defects was also strongly enhanced in fsn-1;
ppm-1 double mutants (Figure 3B). Both alleles of ppm-1
(ok578 or tm653) gave similar levels of enhancement with
fsn-1. The axon termination (hooking) and synaptic branch
extension defects in the PLM neurons of glo-4, ppm-1 double
Figure 3 ppm-1 regulates synaptic branch extension/stabilization in PLM neurons. (A) Defects in synaptic branch extension in the PLM neurons were
visualized using muIs32[Pmec7GFP] in wild type or the indicated mutant genotypes. Images correspond to the boxed region of the diagram. Arrowhead
highlights the absence of the synaptic branch. (B) Quantitation of the defects in synaptic branch extension in the PLM neurons for the indicated
genotypes. Note that the percentage of PLM axons that are wild type for each genotype is not shown. Analysis was performed on young adults grown
at 23 , unless otherwise speciﬁed. Bar, 10 mm. Error bars represent the standard error of the mean. Signiﬁcance was determined using an unpaired
t-test, where n represents the number of independent counts of 10–30 worms for a given genotype. *P , 0.05, ***P , 0.001; ns, not signiﬁcant.
ppm-1 Regulates Axon Termination 1301mutants were also enhanced (Figures 2B and 3B). In contrast,
axon termination and branch extension defects in the PLM
neurons of glo-1; ppm-1 double mutants and glo-1; fsn-1;
ppm-1 triple mutants were increased, but not enhanced (Fig-
ures 2B and 3B). fsn-1; glo-4, ppm-1 triple mutants were not
analyzed as fsn-1; glo-4 double mutants have maximal phe-
notypes (Figures 2B and 3B) (Grill et al. 2007).
To test whether the two alleles of ppm-1 analyzed were
null mutants, we performed trans-heterozygous analysis.
With regard to the PLM neurons, fsn-1; ok578/tm653
mutants showed enhanced penetrance of defects in axon
termination and synaptic branch extension (Figures 2B
and 3B) that were not signiﬁcantly different from fsn-1;
ppm-1(ok578) and fsn-1; ppm-1(tm653) double mutants.
These results are consistent with ok578 and tm653 acting
as null alleles of ppm-1 in the PLM neurons. In the ALM
neurons, fsn-1; ok578/tm653 had an increased percentage
of neurons showing big hooks compared to fsn-1 single
mutants; however, levels were not increased to the same
extent as fsn-1; ppm-1(ok578) and fsn-1; ppm-1(tm653).
Thus, in the ALM neurons the genes used as visible markers
to generate fsn-1; ok578/tm653 animals (dpy-11 and unc-42)
may affect ppm-1,o rt h eALM neurons may be less sensitive
to ppm-1 loss of function.
Overall, our data are consistent with a model in which
ppm-1 functions in a parallel pathway to fsn-1 and glo-4 to
regulate axon termination and synaptic branch extension/
stabilization in the PLM mechanosensory neurons.
ppm-1 regulates synapse formation in GABAergic
motor neurons
Previous studies have shown that rpm-1 regulates synapse
formation in the motor neurons (Zhen et al. 2000; Nakata
et al. 2005). The presynaptic terminals formed by the
GABAergic dorsal D type (DD) motor neurons can be visu-
alized with Synaptobrevin (SNB)-1 fused to GFP (GFP::
SNB-1). In wild-type animals, GFP::SNB-1 puncta of the
DD neurons are evenly distributed along the dorsal nerve
Figure 4 ppm-1 regulates synapse formation in GABAergic motor neurons. (A) Presynaptic terminals of DD neurons were visualized using juIs1[Punc-25
SNB-1::GFP] in wild type or mutant genotypes. Arrows highlight the gaps between presynaptic puncta in the dorsal cord. (B) Quantitation of the average
number of SNB-1::GFP puncta per 100 mm of dorsal cord. Analysis was performed on young adults grown at 25 . Bar, 10 mm. Signiﬁcance was determined
using a Student’s t-test, and error bars represent the standard error of the mean. ***P , 0.001; ns, not signiﬁcant.
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ganized GFP::SNB-1 puncta with gaps and aggregation (Fig-
ure 4A). While ppm-1(lf) animals are normal, fsn-1; ppm-1
and glo-4, ppm-1 double mutants are enhanced with signif-
icant disorganization of GFP::SNB-1 puncta (Figure 4A) and
reduced numbers of SNB-1::GFP puncta (Figure 4B). glo-1;
ppm-1 double mutants had reduced numbers of SNB-1::GFP
puncta, but defects were too mild to constitute enhancement
(Figure 4B, P , 0.05). We also observed that ppm-1, rpm-1
double mutants have similar defects as those in rpm-1(lf)
mutants. Importantly, synapse formation defects in rpm-1(lf)
mutants are not saturated, as defects become signiﬁcantly
worse in rpm-1; syd-2 double mutants (Liao et al. 2004).
Therefore, our observations are consistent with ppm-1 reg-
ulating synapse formation by functioning in the same ge-
netic pathway as rpm-1, and a parallel genetic pathway to
fsn-1 and glo-4.
ppm-1 functions in mechanosensory neurons
downstream of rpm-1
rpm-1 and its downstream signaling molecules, glo-4 and
glo-1, act cell autonomously in mechanosensory neurons
(Schaefer et al. 2000; Grill et al. 2007). To determine
whether ppm-1 functions cell autonomously, we performed
transgenic rescue experiments in which ppm-1 expression
was driven by different promoters. Transgenic expression
of ppm-1 using either a fosmid (native ppm-1 promoter),
Prgef-1 (a pan-neuronal promoter), or Pmec-7 (a mechano-
sensory neuron promoter) rescued PLM axon termination
defects in both ppm-1 single mutants and fsn-1; ppm-1 dou-
ble mutants (Figure 5A). Previous studies identiﬁed a single
point mutation (D239N) that results in a 4000-fold decrease
in phosphatase activity in human PP2Ca (Jackson et al.
2003) (Figure 1A). ppm-1 that is mutated at the correspond-
ing residue (D246N), and presumably catalytically inactive,
did not rescue the enhanced axon termination defects in
fsn-1; ppm-1 double mutants (Figure 5A). These results
demonstrate that ppm-1 regulates axon termination through
its phosphatase activity, and that the lesion in ok578 causes
the enhanced penetrance of axon termination defects ob-
served in ppm-1; fsn-1 double mutants.
Our genetic analysis described earlier indicates that
ppm-1 functions in the same genetic pathway as rpm-1.T o
determine whether ppm-1 functions up or downstream of
rpm-1, we generated transgenic animals that overexpress
PPM-1 in the mechanosensory neurons of rpm-1(lf)
mutants. Overexpression of PPM-1 strongly, but partially,
reduced the axon termination defects in rpm-1(lf) mutants
(Figure 5B). In contrast, phosphatase-dead PPM-1 did not
rescue axon termination defects in rpm-1(lf) mutants
Figure 5 Transgenic expression of
ppm-1 in the mechanosensory
neurons rescues ppm-1(lf)d e f e c t s
in axon termination. (A) Recue of
axon termination defects in the
PLM neurons of ppm-1 or fsn-1;
ppm-1 mutants by transgenic ex-
pression of PPM-1 using the indi-
cated promoters. The percentage
of PLM axons that overextend only
(white) or overextend and hook
(gray) are shown. The percentage
of PLM neurons with normal axon
termination is not shown. For all
transgenes, the data shown are
from two to three transgenic lines,
except for the fosmid wrm613bH10
(Exppm-1) in which only one trans-
genic line was analyzed. (B) Axon
termination defects in rpm-1(lf)
mutants are partially rescued by
transgenic expression of PPM-1,
but not by transgenic expression
of phosphatase-dead PPM-1
(D246N). The data shown are from
two to three transgenic lines for
each genotype. Analysis was per-
formed on young adults grown at
23 . Error bars represent the stan-
dard error of the mean. Signiﬁ-
cance was determined using an
unpaired t-test, where n represents
the number of independent counts
of 10–30 worms for a given geno-
type. *P , 0.05, ***P , 0.001.
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tioning as a phosphatase that acts downstream of rpm-1.
ppm-1 negatively regulates the DLK-1 pathway
Previous studies have shown that the orthologs of PPM-1
can act at the level of MKKK, MKK, or MAPK to negatively
regulate a kinase cascade (Takekawa et al. 1998; Hanada
et al. 2001). These observations suggested that phenotypes
in ppm-1(lf) mutants might be due to excess activation of
dlk-1, mkk-4, and/or pmk-3. To address this question, we
employed two experimental strategies. First, we used
a transgenic approach to test whether ppm-1 negatively reg-
ulates the DLK-1 pathway. Overexpression of DLK-1 resulted
in similar severity and penetrance of phenotypes as those
seen in rpm-1(lf) mutants including axon termination
defects in the ALM (Figure 6A) and PLM neurons (Figure
6B), and defects in synaptic branch extension in the PLM
neurons (data not shown). Coexpression of PPM-1, but not
phosphatase-dead PPM-1, partially rescued the defects
caused by overexpression of DLK-1 (Figure 6, A and B). This
observation suggests that PPM-1 acts as a phosphatase to
negatively regulate the DLK-1 pathway.
Next, we used a genetic approach to determine which
kinase in the DLK-1 pathway might be a target of PPM-1’s
Figure 6 ppm-1 negatively re-
gulates the dlk-1 pathway. Trans-
genic expression of DLK-1 causes
axon termination defects in
(A) ALM neurons and (B) PLM
neurons, which is suppressed by
coexpression of PPM-1, but
not phosphatase-dead PPM-1
(D246N). The data shown are
pooled from three or more trans-
genic lines, except the data for
phosphatase-dead PPM-1, which
are from a single transgenic line.
The percentage of PLM axons
that hook are shown. The per-
centage of PLM neurons that
overextend or are wild type is
not shown. (C) Analysis of sup-
pression of ppm-1 mutant phe-
notypes by loss of function in
dlk-1, mkk-4, and pmk-3. Quan-
titation of axon termination
defects (overextension only) is
shown in the indicated mutant
genotypes. Note that only pmk-
32/2; ppm-12/2 mutant animals
show a signiﬁcant suppression of
defects in axon termination.
Analysis was performed on
young adults grown at 23 . Error
bars represent the standard error
of the mean. Signiﬁcance was
determined using an unpaired
t-test, where n represents the
number of independent counts
of 10–30 worms for a given ge-
notype. *P , 0.05, **P , 0.005,
***P , 0.001.
1304 E. D. Tulgren et al.phosphatase activity. To do so, we constructed double
mutants of ppm-1 with dlk-1, mkk-4,o rpmk-3. Axon termi-
nation defects (overextension) in the PLM neurons were
analyzed for double mutants and compared to ppm-1(lf)
single mutants. Defects in axon termination were not res-
cued in dlk-1; ppm-1 and mkk-4; ppm-1 double mutants
(Figure 6C). In contrast, axon termination defects in
pmk-3; ppm-1 double mutants were signiﬁcantly reduced
compared to ppm-1(lf) single mutants (Figure 6C). These
observations are consistent with excess pmk-3 function lead-
ing to axon termination defects in ppm-1(lf) mutants.
PPM-1 localizes to the presynaptic terminals of
motor neurons
Given that ppm-1 functions in neurons, we wanted to test
whether it is expressed in neurons. To address this question,
we generated transgenic animals in which the 3.7-kb pro-
moter of ppm-1 drives expression of GFP. Pppm-1GFP is
expressed in neurons of the nerve ring and motor neurons
of the ventral nerve cord (Figure 7A). Since ppm-1 is
expressed in motor neurons, we used a transgenic approach
to study the subcellular distribution of PPM-1 in the
GABAergic DD and VD motor neurons. We generated trans-
genic animals that express a fusion protein of mCherry and
PPM-1, and a fusion protein of GFP and SNB-1, a synaptic
vesicle membrane protein. SNB-1::GFP localizes to presyn-
aptic puncta in the dorsal cord where the DD neurons in-
nervate muscle (Figure 7B). While mCherry::PPM-1 was not
always punctate, mCherry::PPM-1 puncta were observed in
the dorsal cord and colocalized with GFP::SNB-1 (Figure
7B). These results demonstrate that PPM-1 can localize to
the presynaptic terminals of GABAergic motor neurons.
Discussion
RPM-1 functions as part of an E3 ubiquitin ligase/SCF com-
plex that includes FSN-1. This complex ubiquitinates and
destroys DLK-1 to negatively regulate a MAP kinase pathway
(Nakata et al. 2005). RPM-1 is part of a conserved protein
family called PHR proteins, and PHR proteins in ﬂies and
mice also function as part of SCF complexes to regulate
synapse formation and neuronal development (Burgess
et al. 2004; Collins et al. 2006; Lewcock et al. 2007; Wu
et al. 2007; Saiga et al. 2009; Tada et al. 2009). Thus, neg-
ative regulation of the DLK-1/Dlk pathway represents an
essential, evolutionarily conserved function of the PHR pro-
teins. While PHR proteins represent one mechanism for neg-
atively regulating the DLK-1 pathway, it remains uncertain if
other, complementary mechanisms also restrain the activity
of this pathway. Here we provide evidence of a conserved
PP2Ca/b phosphatase, PPM-1, that also negatively regu-
lates the DLK-1 pathway.
Our analysis shows that loss of function in ppm-1 results
in relatively mild phenotypes compared to rpm-1, and that
ppm-1(lf) enhances fsn-1 and glo-4(lf). This ﬁnding explains
why ppm-1 mutants were not isolated in previous genetic
Figure 7 PPM-1 is expressed in neurons and localizes to
presynaptic terminals. (A) Transgenic worms that use the
3.7-kb promoter of ppm-1 (F25D1.1) to express GFP were
analyzed by epiﬂuorescent microscopy. GFP is expressed
broadly by the ppm-1 promoter (upper image), and is
present in neurons of the ventral cord (arrows, lower left
image), and the nerve ring (arrow, lower right image). (B)
Confocal microscopy was used to analyze transgenic worms
that express mCherry::PPM-1 (red) and GFP::SNB-1 (green)
speciﬁcally in the GABAergic motor neurons using the unc-
25 promoter. mCherry::PPM-1 colocalizes with GFP::SNB-1
at presynaptic terminals in the dorsal nerve cord.
ppm-1 Regulates Axon Termination 1305screens for mutants with defective axon termination or syn-
apse formation. Our observations are consistent with ppm-1
functioning in a genetic pathway that is parallel to both fsn-1
and glo-4.
With regard to axon termination in the PLM neurons, and
synapse formation in the GABAergic motor neurons, we ob-
served that glo-4, ppm-1 double mutants were enhanced,
and glo-1; ppm-1 double mutants were not enhanced. This
observation suggests that glo-4 plays a greater role in axon
termination and synapse formation than glo-1. This interpre-
tation is consistent with our observations that glo-4 has
stronger enhancer effects than glo-1 with fsn-1 (Grill et al.
2007) (Figure 1–4). Presumably a certain level of reduced
GLO pathway function is needed to enhance ppm-1(lf).
While glo-4(lf) achieves this level of inactivation of the
GLO pathway, glo-1 does not. This model suggests that an
unidentiﬁed small GTPase or signaling molecule, besides
GLO-1, functions downstream of GLO-4. Presumably loss
of function in both glo-1 and this other molecule(s) is re-
quired to enhance ppm-1(lf).
Our observation that ppm-1(lf) does not enhance rpm-1(lf)
demonstrates that ppm-1 functions in the same genetic path-
way as rpm-1. This is consistent with our transgenic experi-
ments showing that ppm-1 functions downstream of rpm-1 to
negatively regulate the DLK-1 pathway. Suppression of ppm-1
axon termination defects by pmk-3(lf) suggests that PPM-1
may negatively regulate PMK-3 directly by dephosphoryla-
tion. Alternatively, PPM-1 may negatively regulate a positive
regulator of PMK-3,s u c ha sUEV-3. Future biochemical
experiments aimed at testing whether PPM-1 regulates the
phosphorylation of PMK-3 should provide a deﬁnitive an-
swer to this question.
It is not immediately clear to us why only pmk-3(lf) sup-
presses ppm-1(lf) defects. We anticipated that loss of func-
tion in any component of the DLK-1 pathway would prevent
activation of this pathway and suppress phenotypes caused
by ppm-1(lf). One explanation for our results is that kinases
other than DLK-1 and MKK-4 also function upstream of
PMK-3, and suppression only occurs with loss of function
in the target of PPM-1, presumably PMK-3. Mixed Lineage
Kinase (MLK)-1 was recently shown to function upstream of
PMK-3 in the context of axon regeneration (Nix et al. 2011),
and is a likely candidate as an alternative mechanism for
activation of PMK-3 in the context of development.
Importantly, the dlk-1 pathway is required not just in a de-
velopmental context, but also for axon regeneration in the
mechanosensory neurons (Yan et al. 2009) and in the motor
neurons of adult C. elegans (Hammarlund et al. 2009). Over-
expression of dlk-1,o rl o s so ff u n c t i o ni nrpm-1 or fsn-1,l e a d s
to improved axon regeneration (Hammarlund et al. 2009).
Our discovery that ppm-1 is a negative regulator of the dlk-1
pathway, similar to rpm-1 and fsn-1,s u g g e s t st h a tppm-1 may
also function in axon regeneration. Given our ﬁnding that
ppm-1 enhances fsn-1 with regard to defects in both axon
termination and synapse formation, it is plausible that
fsn-1; ppm-1 double mutants may also show enhanced
increases in axon regeneration. Future experiments aimed
at addressing this possibility will be informative.
In summary, our study provides new insight into the
molecular mechanisms of axon termination and synapse
formation by showing that PPM-1 constitutes a new regula-
tory mechanism to control signaling through the DLK-1
pathway. Our study highlights the potential importance of
the PP2C/PPM phosphatases in neuronal development.
Addressing whether other members of the PP2C/PPM family
function in axon termination and/or synapse formation
remains an important goal for the future.
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